Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...
- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...
ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...
ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1118 | -4.55991516437 | 2.4518 | 2.6571 | 2.3066 | 12117 | 2.39832252 | CS |
| 4 | -0.26 | -10 | 2.6 | 2.87 | 2.29 | 23851 | 2.50168235 | CS |
| 12 | -1.21 | -34.0845070423 | 3.55 | 5.29 | 1.62 | 92130 | 3.56164515 | CS |
| 26 | -1.21 | -34.0845070423 | 3.55 | 5.29 | 1.62 | 92130 | 3.56164515 | CS |
| 52 | -1.21 | -34.0845070423 | 3.55 | 5.29 | 1.62 | 92130 | 3.56164515 | CS |
| 156 | -1.21 | -34.0845070423 | 3.55 | 5.29 | 1.62 | 92130 | 3.56164515 | CS |
| 260 | -1.21 | -34.0845070423 | 3.55 | 5.29 | 1.62 | 92130 | 3.56164515 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
